Oxaliplatin

ATP binding cassette subfamily B member 1 ; Homo sapiens







25 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35165262 DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer. 2022 Feb 14 2
2 35426328 Polysaccharides Produced by the Mushroom Trametes robiniophila Murr Boosts the Sensitivity of Hepatoma Cells to Oxaliplatin via the miR-224-5p/ABCB1/P-gp Axis. 2022 Jan-Dec 1
3 35474580 In vitro exosomal transfer of Nrf2 led to the oxaliplatin resistance in human colorectal cancer LS174T cells. 2022 Jun 1
4 33824865 TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell. 2021 1
5 34286514 LncRNA PCGEM1 mediates oxaliplatin resistance in hepatocellular carcinoma via miR-129-5p/ETV1 axis in vitro. 2021 Aug 1
6 32222024 Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis. 2020 May 1
7 33035787 Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma. 2020 Dec 1
8 30539797 miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. 2019 Feb 2
9 31040701 SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway. 2019 4
10 31258699 Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism. 2019 Jul 1
11 31907114 Verapamil enhances the sensitivity of oxaliplatin to tumor cells by influencing the PARP pathway. 2019 Dec 1 2
12 29710482 Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361. 2018 Mar 1
13 30372807 Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p. 2018 Dec 3
14 28217977 miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression. 2017 Jun 2
15 27245421 Stanniocalcin 2 induces oxaliplatin resistance in colorectal cancer cells by upregulating P-glycoprotein. 2016 Sep 2
16 26025411 siRNA-mediated silencing of MDR1 reverses the resistance to oxaliplatin in SW480/OxR colon cancer cells. 2015 May 28 4
17 26124005 Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity. 2015 Dec 1
18 24515389 Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells. 2014 Jun 1
19 23525071 Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. 2013 Jul 1
20 23543295 Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer. 2013 Jun 1
21 23746184 Association of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis. 2013 Jun 2
22 23803084 Associations of ABCB1 and XPC genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis in a Chinese population. 2013 1
23 20168208 Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells. 2010 Jun 1
24 19000447 [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues]. 2008 Nov 3
25 16836929 [The lethal effect of combined MDR1 antisense RNA with oxaliplatin and 5-FU on drug-resistant rectal carcinoma cells]. 2006 Jun 1 2